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1. Introduction 
1.1 Preliminary considerations: Focus on cocaine and heroin 
It is well established that several psychoactive substances can lead to addiction. These 
include legal drugs such as alcohol and nicotine which generate the major part of the 
addiction-related social and economical costs to modern societies (1), and a pleiad of illegal 
drugs amongst which cannabis, cocaine and heroin are the most commonly used. 
When one wants to consider the harmful consequences of an addictive drug, both the 
dependence and physical harm potencies of the drug should be considered for these two 
aspects contribute to the deterioration of the user’s life. A recent classification of the major 
classes of addictive drugs reveals that heroin and cocaine are clearly the most dangerous 
ones since both their addictive properties and physical harm potency are high (2). Cocaine 
and heroin are followed by barbiturates and street methadone, but tobacco is shown to have 
addictive property of the same magnitude as cocaine, thereby demonstrating that the legal 
status of a substance is not a predictive factor of least addictive properties. 
In the present chapter, we will consider exclusively cocaine and heroin addictions, not only 
because these two drugs are clearly the most dangerous ones, but mainly because cocaine 
and heroin use have been increasing among western countries populations in the last ten 
years. This focus is one limitation of the general conclusions that will be provided in the 
following chapters that will also address alcoholism and food addiction that will be joined 
by another addiction, namely pathological gambling, in the clinical definition of addictions 
in the upcoming DSM-V. Thus, addictions are increasingly recognised as abnormal 
persistent maladaptive behaviours driven by specific, initially reinforcing, stimuli in the 
environment that are not anymore restricted to psychoactive substances. 
1.2 Drug use: A behaviour as old as humankind? 
Drug use seems to have entered human customs as early as the emergence of human 
societies. Evidences that recreational drug use has emerged early on after human 
sedentarisation, perhaps with the development of religious rites, can be found for several 
drugs and routes of administration. 
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Fig. 1. Rational scale to assess the harm of drugs of potential misuse, after (2).  
The addictive potential of a drug varies from substance to substance, and from individual to 
individual. Dose, frequency, pharmacokinetics of a particular substance, route of 
administration, and time are critical factors for physical harm and addictive potency. Heroin 
and cocaine are clearly the most dangerous ones since both their addictive properties and 
physical harm potency are high. 
Thus, 5000 B.C. the sumerians used opium, as suggested by the fact that they had an 
ideogram for it which has been translated as HUL, meaning « joy » or « rejoicing » (3). A 
3500 B.C. egyptian papyrus provides the earliest historical record of the production of 
alcohol in the description of a brewery (4). 
Interestingly, 3000 B.C. is also the approximate date of the supposed origin of the use of tea 
in China. It is likely that coca leaf chewing began in the Andes at the same time since traces 
of coca have been found in mummies dating 3000 years back (5). The cocaine content of coca 
leaf is under 1% but after 1859, when cocaine was first isolated from coca leaf by Albert 
Niemann, cocaine was available legally in concentrations that were nearly 100% pure. 
Cocaine was first used recreationally in the 1860s, almost as soon as it was synthesised. A 
few years after its synthesis by Richard Willstätter in 1898 (6), cocaine appeared in 
cigarettes, ointments, nasal sprays, and tonics. The most popular cocaine-based product was 
Mariani Wine (Vin Mariani). It was a wine and cocaine mixture that was launched in 1863. 
Nearly all popular personalities of the day, including Queen Victoria, Thomas Edison and 
Pope Leon XIII endorsed it. Cocaine has also been popularised by Sigmund Freud who 
prescribed it for the treatment of digestive disorders, asthma, depression or opiate and 
alcohol dependence (7). 
At the same time, more precisely in 1898, heroin (diacetylmorphine) was synthesized by 
Felix Hoffmann, 23 years after a first academic synthesis by Alder Wright. Akin to the 
launch of cocaine as a medicine, heroin was then introduced by Bayer as “safe preparation 
free from addiction-forming properties“. 
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The broad availability of the pure form of cocaine and heroin has contributed to the marked 
development of addiction to these substances which, in their primary forms and routes of 
administration, were far less addictive. This phenomenon has been suggested to stem from a 
discrepancy between our brain and our modern environment, i.e, Nesse and Berridge wrote 
in 1997: «We are vulnerable to such fitness-decreasing incentives because our brains are not 
designed to cope with ready access to pure drugs, video games, and snack foods. Hundreds 
of generations of exposure would likely shape resistance to their allure and their deleterious 
effects» (8). This interesting consideration suggests that drug addiction may be a matter of 
mismatch between Human evolution and the recent revolution of human environment, a 
problem to which Evolution may be the best solution. 
 
Fig. 2. Illicit drug use state at the beginning of the 21st century  
Top panel: Annual prevalence of global, worldwide, illicit drug use over the period 1998-
2001 (11). Bottom. A trend to increased cocaine use in European countries (10). 
However, before these evolutionary, and rather fatalistic considerations, human societies 
have developed social and legal strategies to cope with addiction, as early as 10 years 
following the synthesis of heroin and cocaine. Indeed, the United States prohibited the 
 
Addictions – From Pathophysiology to Treatment 6 
importation of smoking opium (9) and the manufacture of heroin in 1909 and 1924, 
respectively, while the Harrison Narcotics Act of 1914 prohibited the use of cocaine. Since 
then law enforcement has limited, but not eradicated, heroin and cocaine use, as illustrated 
by figure 2 (EMCDDA) (10), the bottom panel of which shows a general increase in cocaine 
use within European countries over the past 20 years. Such a trend may induce an increase 
in the prevalence of drug-related health problems, and most importantly, of drug addiction. 
1.3 Drug use: An evolutionary feature of animal kingdom 
Drug use seems inherent to animal behaviour, perhaps because of the evolutionary selection of 
a reward system developed to maintain species survival, bringing animals towards sources of 
reinforcement. Thus spontaneous drug use has been observed in several species in the wild. 
Elephants would intoxicate with alcohol contained in ripe fruits and baboons would readily 
eat over-ripe fruits from the marula tree until they cannot walk anymore. Birds also use 
alcohol in that song thrush, for instance, struggle to fly after eating ripe grapes. 
An exhaustive list of examples of spontaneous drug use in animal kingdom is beyond the 
scope of this chapter, but a last example should be enough to emphasise how broad are 
sources of intoxication in mammals: in the south of the United States, sheep and horses eat 
astragalus and then show hyperactive behaviour akin to human beings. 
In experimental settings, it has been demonstrated that all drugs abused by humans are 
reinforcing in many species including planarians (12) and flies (13, 14), and they are readily 
self-administered by vertebrates such as mice (15-21) or rats (22-26), dogs (27, 28) and non 
human primates (29, 30). 
Thus not only is drug used common to several species of the animal kingdom but the 
demonstration that pure forms of psychoactive drugs have reinforcing properties in animals 
under experimental conditions suggests that drug taking is not a specific behavioural 
feature of human beings. Drug use in animals seems rather to be the evidence that the 
neurobiological substrates of primary motivational and reinforcement processes selected by 
evolution have been shaped early on and maintained from planarians to human beings, and 
that drugs highjack these systems. 
However, it remains unclear the extent to which these findings help inform our 
understanding of drug addiction in humans since it is a brain disorder that is clearly far 
removed from primary reinforcement mechanisms. 
2. Drug addiction: A human-specific disorder? 
2.1 What is drug addiction? 
Drug addiction is a complex brain disorder (31), affecting the motivational (32, 33), learning 
(34-37) and behavioural control systems of the brain (38-40). Several definitions of drug 
addiction, ranging from the psychiatric to the social view have been presented by Koob and 
Le Moal (1) and will not be discussed any further. 
Drug addiction is defined as a chronic relapsing compulsive habit characterised by loss of 
control over drug intake, maintained drug use despite adverse consequences (36, 41, 42) and 
the development of negative psycho-affective distress when access to the drug is prevented 
(42, 43). 
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Because the aetiology and pathophysiology of drug addiction remain unknown, this 
prominent psychiatric disorder is best defined by the clinical features of the DSM-IV (44) 
(figure 3). The diagnostic of drug addiction is currently based on a categorial dichotomous 
approach in that the patient must present at least three out of the seven clinical criteria listed 
in figure 5 to be said addicted to a substance. 
 
 
 
Fig. 3. Clinical features of drug addiction according to the DSM-IV-R (44). 
The subject is diagnosed addicted to the substance if they show at least three out of the 7 
clinical criteria over the last 12 months. 
However, all addicted patients are not equally severely affected and a dimensional 
addiction severity scale has been developed to assess general behavioural, health and social 
drug-induced impairments (45-49). 
Indeed, drug addicts do not only take drugs, they spend great amounts of time foraging 
for their drugs, compulsively take drugs, lose control over drug intake, and persist in 
taking drugs despite the many adverse consequences of doing so, including 
compromising their health, family relationships, friendships and work. Many drug 
addicts resort to criminal behaviour to obtain the funds necessary to sustain their 
compulsive drug use and the great majority eventually relapse to drug use even after 
prolonged periods of abstinence. 
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This negative behavioural picture illustrates how drug addiction is not merely a drug taking 
disorder. Indeed, among the individuals exposed to drugs, and there are many who 
occasionally drink only a glass or two of an alcoholic beverage, or smoke a cigarette or two, 
only 15 to 30% overall will switch from casual, ‘recreational’ drug use to drug abuse and 
drug addiction (1, 50) (figure 4). 
 
Fig. 4. We are not equally vulnerable to drug addiction 
A substantial proportion of the general population experiences drugs at least once in a 
lifetime. Of the recreational users who control their drug intake, some will shift to more 
chronic drug use. Only a subgroup of these individuals will develop drug abuse and 
eventually drug addiction. Epidemiological studies reveal that of the individuals who have 
been exposed to addictive drugs, 15 to 20 % eventually develop addiction. 
Despite considerable research we still do not understand why some individuals develop a 
compulsive use of drugs nor do we have effective treatments (51) to reduce the substantial 
social and economic burden (52); for review, see (1) of drug addiction (figure 5). 
Nevertheless, there is increasing evidence suggesting that drug addiction results from 
gradual adaptation processes in the brain of vulnerable subjects in response to chronic drug 
exposure. Not only do these between-systems adaptations trigger an emotional allostatic 
state (hedonic allostasis) (1, 53-55) characterised for instance by increased anxiety, irritability 
and depression but they may ultimately lead to a shift in the psychological mechanisms that 
govern drug seeking and drug taking behaviours, including habits (36, 37, 41, 42, 56, 57) as 
aberrant instrumental learning mechanisms controlled by Pavlovian cues, altered 
behavioural control (39, 58-60), decision-making and self-monitoring processes (61, 61). 
Similarly, Everitt and colleagues have argued that, during the development of drug 
addiction, drug seeking is initially goal-directed but becomes habitual, and ultimately 
compulsive, thereby emphasizing the potential importance of maladaptive automatic 
instrumental learning mechanisms and their control by Pavlovian incentive processes, so 
called incentive habits (37, 42), in the emergence of compulsive drug use (35, 37, 42, 59). 
Additionally, drug-induced adaptations may also facilitate the shift from impulsivity to 
compulsivity that has been suggested to occur in the development of drug addiction (figure 
6) whereby only vulnerable subjects would show a transition from impulse-related 
recreational drug use to compulsive drug intake (1). 
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Fig. 5. Strategic targets of therapeutic treatment in the course of drug addiction (reproduced 
from (51)) 
 
Fig. 6. A progressive shift from impulsivity to compulsivity in the development of drug 
addiction (42) 
2.2 Behavioural and psychological profile of drug addicts 
Besides their disinterest for alternative sources of reinforcement and their focus on the drug, 
drug addicts are characterised by several behavioural and cognitive deficits including 
impaired inhibitory control (62-67), decision making (68-75) and insight (76-78). 
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However, major differences can be observed between addicts depending on their preferred 
drug of abuse. For instance, although opiate and stimulant addicts both display increased 
sensation seeking (79-81) and impulsivity (82-87), they nevertheless differ in other respects, 
with heroin addicts showing greater anxiety than cocaine addicts (88), while the latter 
display higher impulsivity (62, 89, 90). 
Thus not only are several personality traits, including sensation seeking, anxiety and 
impulsivity, associated with increased vulnerability to use drugs (91-94), but different 
personality traits are preferentially associated with use (95) and addiction to specific 
drugs (91, 92, 94, 96-103). It is therefore possible that heroin and cocaine addicts may self-
medicate different personality characteristics or affective states (104-107), with 
impulsivity being preferentially self-medicated by cocaine use. However, as discussed in 
chapter 2 of this book, the relative contribution of a behavioural trait to the choice of a 
drug does not necessarily predict its implication in the transition to compulsive drug use. 
Drug addicts also show several comorbid psychiatric disorders (108-111), as stated by 
O’Brien (112): «Psychiatric disorders commonly coexist with addictive disorders. These 
include anxiety disorders, psychotic disorders, and affective disorders such as depression. 
Although some of these so-called “dual diagnosis” cases are simply a coincidental 
occurrence of common disorders, the overlap is greater than would be expected by chance 
on the basis of population prevalences (109)». However, it remains unknown whether 
comorbid elements contribute to increased vulnerability to drug addiction (113) or 
whether chronic drug exposure facilitates the emergence of psychiatric comorbidity (for 
discussion see (112)). Similarly, while some personality, or behavioural, traits are 
triggered by chronic drug use, there is evidence that personality variables are associated 
with increased vulnerability to develop drug addiction (92, 114). This rather blur picture 
not only suggests that several sub-populations exist within drug addicts (115), but it 
clearly illustrates how little is known about the factors involved in the vulnerability to 
develop drug addiction. 
To date a triadic model of contributing factors has been established that accounts well for 
both clinical and preclinical literature. Thus, vulnerability to drug addiction is suggested to 
result from the interaction between a vulnerable phenotype, or personality (being the 
interaction between genes and history), the drug and the environment (figure 7). 
There is clearly a genetic vulnerability to addiction. Genetic factors may contribute up to 40% 
to the development of drug addiction (51). This estimation gives genetic factors a limited 
contribution to the vulnerability to drug addiction and highlights the importance of both the 
drug and the environment in the development of the pathology. There is indeed compelling 
evidence that life experiences and environments highly influence the effects of drugs of abuse 
and play a critical role in the transition from controlled to compulsive drug use (116, 117). For 
instance, drug addiction seems to be more frequent in people living in degraded areas or in 
people that undergo difficult experiences during their childhood. Such specific environmental 
conditions at either perinatal, developmental or adulthood stages may alter one’s personality 
construction so that they become more vulnerable to use or abuse drugs (118). On the other 
hand, positive family relationships, friendships, involvement and attachment appear to 
somehow protect against the development of drug addiction (119, 120). 
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Fig. 7. Triad of influences underlying vulnerability to drug addiction 
A number of interacting factors are hypothesised to influence the pathway to addiction, 
including biological determinants (genes), drug exposure and the environment. Genetic 
influences may account for up to 40% of the vulnerability for drug addiction  
Thus, the present general strategies developed to treat addictions should perhaps be re-
oriented towards a more patient-based medication strategy once better insights are gained 
in the understanding of the etiological and neurobiological substrates of individual 
vulnerabilities to addictions. 
2.3 Biological correlates of drug addiction in humans: Insights from imaging studies 
An exhaustive synthesis of the neurobiological correlates of drug addiction is beyond the 
scope of this chapter. Overall, drug exposure impacts both brain structure and function. 
Thus at the morphological level, drug addicts have decreased grey matter volumes in 
prefrontal (121-125) and cerebellar regions of the brain (126). Functionally, when presented 
with drug-related cues that induce craving, drug addicts show abnormal activation of limbic 
structures including the amygdala (127, 128), the insular (40, 129) and orbitofrontal cortices 
(39, 130) as well as cognitive prefrontal areas such as the cingulate (127, 128, 131) and 
dorsolateral prefrontal cortices (74). 
Moreover, drug addicts are characterised by decreased levels of striatal D2/3 dopamine 
receptors (132-134) and reduced metabolism in the orbitofrontal cortex (132). These two 
alterations are highly correlated (132), thereby providing the orbitofrontal-limbic striatum 
circuit a prominent implication in addiction (134, 135), even though other networks, including 
the thalamo-cortical systems, have been identified to be impaired in drug addicts (136). 
Interestingly, a growing body of evidence points towards an implication of non limbic 
striatal areas in the pathophysiology of drug addiction since dopamine transmission is 
specifically increased in the dorsal striatum of cocaine addicts experiencing craving in 
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response to presentation of drug-associated cues (137, 138), providing a neurobiological 
evidence for a progressive involvement of dorsal striatum-dependent habits (139-141) in 
drug addiction (35-37, 41, 42). 
A major limitation of human studies is that the data obtained, though clearly informative, 
are based on the comparison of current or former drug addicts and drug naive control 
subjects. Thereby, human studies cannot control for the effects of protracted drug exposure 
on the brain nor can they define whether the abnormalities observed in drug addicts are a 
pathological biological adaptation to drug exposure or predated drug use and hence are 
instead endophenotypes of vulnerability to drug addiction. 
This is where the case for animal experimentation in addiction research is revealed 
compelling. Besides the aforementioned limitations, studies in human addicts are often 
prone to interpretative issues not least due to inter-subject variability in drug exposure, the 
frequent co-abuse of several drugs often in combination with alcohol, cannabis and nicotine, 
the regular occurrence of co-morbid brain disorders such as depression, conduct disorder 
and attention-deficit/hyperactivity disorder (ADHD) and the difficulty in controlling pre-
morbid cognitive and intellectual abilities. 
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